Salta al contenuto principale
Passa alla visualizzazione normale.

MIRIAM GAGGIANESI

Pubblicazioni

Data Titolo Tipologia Scheda
2024 Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory Articolo in rivista Vai
2023 EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas Articolo in rivista Vai
2023 Recapitulating thyroid cancer histotypes through engineering embryonic stem cells Articolo in rivista Vai
2022 Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development Articolo in rivista Vai
2022 Cancer cell targeting by CAR-T cells: A matter of stemness Review essay (rassegna critica) Vai
2022 Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy Review essay (rassegna critica) Vai
2022 Targeting epigenetic alterations in cancer stem cells Review essay (rassegna critica) Vai
2022 Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy Review essay (rassegna critica) Vai
2022 Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer Articolo in rivista Vai
2022 Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells Articolo in rivista Vai
2022 Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 Articolo in rivista Vai
2021 FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter Articolo in rivista Vai
2021 Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery Articolo in rivista Vai
2021 PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells Articolo in rivista Vai
2021 CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin Articolo in rivista Vai
2021 Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment Review essay (rassegna critica) Vai
2021 Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy Articolo in rivista Vai
2020 Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis Articolo in rivista Vai
2019 Cancer Stem Cells: From Birth to Death Capitolo o Saggio Vai
2019 Meeting the Challenge of Targeting Cancer Stem Cells Articolo in rivista Vai
2018 MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state Articolo in rivista Vai
2017 IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition Articolo in rivista Vai
2016 MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b Articolo in rivista Vai
2016 ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis Articolo in rivista Vai
2014 CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis Articolo in rivista Vai
2011 Diacylglycerol kinase α mediatses 17-β-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30 Articolo in rivista Vai
2011 Colorectal cancer stem cells and cell death Review essay (rassegna critica) Vai
2010 Negative regulation of diacylglycerol kinase mediates adenosine-dependent hepatocyte preconditioning Articolo in rivista Vai